Follow The Filings

NATR Natures Sunshine Products Inc.

Health Care, filed as NATURES SUNSHINE PRODS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • $2.2M

Who owns NATR

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management <0.01% Hold 98,800 $2.2M History

Insider trades

Open-market buys and sales by NATR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NATR insider trades
  • $2.6M bought by 1 insider
  • $2.1M sold by 5 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Prescott Group Capital Management, L.l.c. 10% owner, +4 joint filers
    Buy
    $294K 20,000 shares at $14.69 +1% to stake
    Traded Aug 17 Filed Aug 19
  2. Prescott Group Capital Management, L.l.c. 10% owner, +4 joint filers
    Buy
    $2.3M 141,389 shares at $16.40 +7.9% to stake
    Traded Aug 6–10 Filed Aug 10
  3. Kevin R. Herbert EVP & President, North America
    Sale
    $41K 2,000 shares at $20.68 3.9% of stake
    Traded Jun 12 Filed Jun 15
  4. Bryant J Yates EVP & President, Europe
    Sale
    $238K 11,968 shares at $19.90 13% of stake
    Traded Jun 5 Filed Jun 11
  5. Daniel C Norman EVP & President, Asia
    Sale
    $200K 9,713 shares at $20.64 17% of stake
    Traded Jun 1 Filed Jun 3
  6. Nathan G Brower EVP, General Counsel
    Sale
    $262K 12,015 shares at $21.84 22% of stake
    Traded May 21 Filed May 22
  7. Bryant J Yates EVP & President, Europe
    Sale
    $475K 19,516 shares at $24.35 19% of stake
    Traded Mar 13 Filed Mar 17
  8. Daniel C Norman EVP & President, Asia
    Sale
    $377K 15,383 shares at $24.52 22% of stake
    Traded Mar 13 Filed Mar 17
  9. Jonathan David Lanoy SVP, Chief Accounting Officer
    Sale
    $99K 4,000 shares at $24.70 7.9% of stake
    Traded Mar 13 Filed Mar 16
  10. Bryant J Yates EVP & President, Europe
    Sale
    $38K 1,700 shares at $22.29 1.7% of stake
    Traded Dec 12, 2025 Filed Dec 16, 2025
  11. Daniel C Norman EVP & President, Asia
    Sale
    $182K 8,884 shares at $20.46 12% of stake
    Traded Nov 12, 2025 Filed Nov 19, 2025
  12. Jonathan David Lanoy SVP, Chief Accounting Officer
    Sale
    $102K 5,000 shares at $20.45 9.8% of stake
    Traded Nov 18, 2025 Filed Nov 19, 2025
  13. Nathan G Brower EVP, General Counsel
    Sale
    $79K 3,800 shares at $20.81 7.5% of stake
    Traded Nov 14, 2025 Filed Nov 18, 2025

Also filed in the last 12 months, not counted as buying or selling: 54 share withholdings for taxes, 35 option exercises, 29 stock grants, 9 other transactions, and 3 gifts.

SEC filings

Recent issuer filings from EDGAR, 6 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
8-K 2.02,5.02,9.01
10-Q
8-K 5.02,9.01
10-Q
8-K 2.02,5.02,5.07,9.01

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $445.32M $454.36M $480.14M
Gross profit $321.13M $324.69M $347.72M
Gross margin * 72.1% 71.5% 72.4%
Net income $15.08M $7.7M $19.52M
Net margin * 3.4% 1.7% 4.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $165.82M $160.58M $178.84M
Total non-current assets * $83.96M $80.28M $82.3M
Total assets $249.77M $240.86M $261.15M
Total current liabilities $76.75M $65.69M $78.54M
Total non-current liabilities * $13.48M $14.17M $21.06M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $41.23M $25.3M $35.32M
Cash from investing -$10.48M -$10.97M -$6.48M
Cash from financing -$7.96M -$9.9M -$23.77M
Net change in cash $22.34M $2.33M $9.19M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.